BioSig Technologies Receives $4.6 Million in Cash Warrant and Option Exercises
June 03, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, June 03, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Present at the 9th Annual LD Micro Invitational
May 30, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, May 30, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
Electroceuticals/Bioelectric Medicine Market To Reach USD 38.13 Billion By 2026 | Reports And Data
May 28, 2019 12:59 ET
|
Reports And Data
High number of diseases due to rise in geriatric population, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario for...
BioSig Allowed First Key US Patent Claims for its PURE EP™ System
May 23, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, May 23, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version
May 21, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, May 21, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors
May 20, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Completes Patient Cases at Indiana University
May 06, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, May 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig’s Manuscript Accepted to IEEE Engineering in Medicine and Biology Conference 2019
May 02, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, May 02, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig To Participate at Heart Rhythm Society’s Scientific Sessions 2019
April 30, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, April 30, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Completes Successful Patient Cases at Greenville Memorial Hospital
April 16, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, April 16, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...